跳至主要内容
临床试验/NCT04768244
NCT04768244已完成不适用

Impact of Maternal SARS-CoV-2 Infection and Vaccination on Breast Milk Antibodies, Milk Bioactive Compounds and Maternal-child Health (MilkCORONA)

Institute of Agrochemistry and Food Technology, National Research Council2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
2
主要终点
SARS-CoV-2 RNA

研究概览

简要总结

prospective multicenter study The main aim is to study the impact of maternal COVID-19 on breast milk immune, microbiological, and metabolic profile and infant growth and development

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant or nursing women with positive PCR for SARS-CoV-2 in nasopharynge and/or presence of SARS-CoV-2 antibodies in serum determined in hospitals

排除标准

  • aggravation of symptomatology requiring specific treatment and/or hospitalization

结局指标

主要结局

SARS-CoV-2 RNA

时间窗: 1 month

levels of viral RNA from SARS-CoV-2 in breast milk

次要结局

  • infant growth and development(1st year)
  • breast milk metabolite(1st year)
  • infant microbiota(1st year)
  • breast milk immune(1st year)
  • breast milk microbiota(1st year)

研究者

发起方
Institute of Agrochemistry and Food Technology, National Research Council
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Maria Carmen Collado

PhD, Research Scientist

Institute of Agrochemistry and Food Technology, National Research Council

研究点 (2)

Loading locations...

相似试验